Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Finished Goods (2019 - 2023)

Dna X's Finished Goods history spans 5 years, with the latest figure at $3.7 million for Q3 2023.

  • Quarterly results put Finished Goods at $3.7 million for Q3 2023, up 4.66% from a year ago — trailing twelve months through Sep 2023 was $3.7 million (up 4.66% YoY), and the annual figure for FY2022 was $3.5 million, up 17.65%.
  • Finished Goods for Q3 2023 was $3.7 million at Dna X, down from $4.1 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $13.6 million in Q4 2019 to a low of $2.5 million in Q2 2022.
  • The 5-year median for Finished Goods is $4.1 million (2023), against an average of $5.7 million.
  • The sharpest move saw Finished Goods crashed 69.53% in 2022, then surged 67.84% in 2023.
  • Year by year, Finished Goods stood at $13.6 million in 2019, then tumbled by 42.53% to $7.8 million in 2020, then crashed by 62.11% to $3.0 million in 2021, then increased by 17.65% to $3.5 million in 2022, then grew by 7.95% to $3.7 million in 2023.
  • According to Business Quant data, Finished Goods over the past three periods came in at $3.7 million, $4.1 million, and $3.9 million for Q3 2023, Q2 2023, and Q1 2023 respectively.